Sign in

    Daniel Shahrabani

    Research Analyst at FARD Investments

    Daniel Shahrabani is Managing Director and Principal at Fard Investments, specializing in real estate investment and management with a portfolio exceeding 24 commercial and residential properties in Greater Montreal. He covers companies in both Canadian and US real estate markets, advising on complex debt, equity, mezzanine, and CMBS transactions, and was an early innovator in cross-border real estate financing, having founded Chelsea Capital and structured pioneering CMBS deals in Canada. With an MBA from the Stern School of Business, he began his career at BDO Seidman in New York, later joining Fard Investments, and also leads origination for R3 Funding in Canada. He is widely regarded for his expertise in real estate financing solutions, though specific quantitative performance metrics and securities licenses are not publicly listed.

    Daniel Shahrabani's questions to BRCNF leadership

    Daniel Shahrabani's questions to BRCNF leadership • Q1 2025

    Question

    Asked for an update on the former Merit operations and whether the company's current liquidity is sufficient to sustain it until its profitability target in 2026.

    Answer

    The Merit business ceased operations in March 2023, but its assets are still for sale, which Burcon views as a potential upside regardless of the outcome. The company's business plan is considered fully funded to cash flow positive through a combination of cash on hand, a potential debt facility, future sales revenue, and non-dilutive government funding.

    Ask Fintool Equity Research AI

    Daniel Shahrabani's questions to BRCNF leadership • Q3 2024

    Question

    Asked for a timeline on achieving positive cash flow from operations and for an update on the sale of the Merit facility.

    Answer

    The company expects to generate revenue from its hemp protein product within 2024. The situation with the Merit facility is additive to the company's main business plan, and Burcon could benefit in several ways (ownership, licensing, contract manufacturing) once the receiver resolves the sale.

    Ask Fintool Equity Research AI